A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4045 (2006.01) A61K 31/4458 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2500198
The present invention relates to the combined use of methyl phenidate and at least one of melatonin, a melatonin analogue, or a pharmaceutically acceptable salt thereof in the treatment of attention deficit hyperactive disorder (ADHD). Methylphenidate and melatonin or its analogue may be used together or in combination with one or more other active ingredients, and is preferably formulated as a composition for controlled release.
L'invention concerne l'utilisation combinée de méthylphénidate et au moins de mélatonine, d'un analogue de la mélatonine, ou d'un sel pharmaceutiquement acceptable de celle-ci, dans le traitement d'un trouble d'hyperactivité avec déficience de l'attention (ADHD). Le méthylphénidate et la mélatonine ou son analogue peuvent être utilisés ensemble, ou combinés à un ou à plusieurs autres principes actifs, et sont de préférence formulés comme une composition pour une libération commandée.
Osler Hoskin & Harcourt Llp
Pooger Properties Limited
LandOfFree
Combined use of methylphenidate and melatonin for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined use of methylphenidate and melatonin for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined use of methylphenidate and melatonin for treating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1871961